Kristian Kidholm

Kristian Kidholm

Auto-generated profile, based on publicly available information

Kristian Kidholm


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Journal of Medical Internet Research
Verified
Journal Article
Open access
BDBirthe Dinesen
Birthe Dinesen
BNBrandie Nonnecke
Brandie Nonnecke
DLDavid Lindeman
David Lindeman
ETEgon Toft
Egon Toft
KKKristian Kidholm
Kristian Kidholm
TNThomas Nesbitt
Thomas Nesbitt
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

31 July 2017 in Journal of Telemedicine and Telecare
Verified
Journal Article
Closed access
KKKristian Kidholm
Kristian Kidholm
JCJane Clemensen
Jane Clemensen
LCLiam J Caffery
Liam J Caffery
ASAnthony C Smith
Anthony C Smith
The evaluation of telemedicine can be achieved using different evaluation models or theoretical frameworks. This paper presents a scoping review of published studies which have applied the Model for Assessment of Telemedicine (MAST). MAST includes pre-implementation assessment (e.g. by use of participatory design), followed by multidisciplinary assessment, including description of the patients and the application and assessment of safety, clinical effectiveness, patient perspectives, economic aspects organisational aspects and socio-cultural, legal and ethical aspects. Twenty-two studies met the inclusion criteria and were included in the review. In this article, research design and methods used in the multidisciplinary assessment are described, strengths and weaknesses are analysed, and recommendations for future research are presented.

1 November 2015 in Health Policy
Verified
Journal Article
Open access
KKKristian Kidholm
Kristian Kidholm
AØAnne Mette Ølholm
Anne Mette Ølholm
MBMette Birk-Olsen
Mette Birk-Olsen
ACAmerico Cicchetti
Americo Cicchetti
BFBrynjar Fure
Brynjar Fure
LSLaura Sampietro-Colom
Laura Sampietro-Colom
Assessments of new health technologies in Europe are often made at the hospital level. However, the guidelines for health technology assessment (HTA), e.g. the EUnetHTA Core Model, are produced by national HTA organizations and focus on decision-making at the national level. This paper describes the results of an interview study with European hospital managers about their need for information when deciding about investments in new treatments. The study is part of the AdHopHTA project. Face-to-face, structured interviews were conducted with 53 hospital managers from nine European countries. The hospital managers identified the clinical, economic, safety and organizational aspects of new treatments as being the most relevant for decision-making. With regard to economic aspects, the hospital managers typically had a narrower focus on budget impact and reimbursement. In addition to the information included in traditional HTAs, hospital managers sometimes needed information on the political and strategic aspects of new treatments, in particular the relationship between the treatment and the strategic goals of the hospital. If further studies are able to verify our results, guidelines for hospital-based HTA should be altered to reflect the information needs of hospital managers when deciding about investments in new treatments.

7 February 2015 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
LMLisbeth Rosenbek Minet
Lisbeth Rosenbek Minet
LHLine Willads Hansen
Line Willads Hansen
CPClaus Duedal Pedersen
Claus Duedal Pedersen
ITIngrid Louise Titlestad
Ingrid Louise Titlestad
JCJette Krøjgaard Christensen
Jette Krøjgaard Christensen
LMLilian Møllegård
Lilian Møllegård
An essential element in the treatment of patients with chronic obstructive pulmonary disease (COPD) is rehabilitation, of which supervised training is an important part. However, not all individuals with severe COPD can participate in the rehabilitation provided by hospitals and municipal training centres due to distance to the training venues and transportation difficulties. The aim of the study was to assess the feasibility of an individualized home-based training and counselling programme via video conference to patients with severe COPD after hospitalization including assessment of safety, clinical outcomes, patients’ perceptions, organisational aspects and economic aspects. The design was a pre- and post-test intervention study. Fifty patients with severe COPD were included. The telemedicine training and counselling included three weekly supervised exercise sessions by a physiotherapist and up to two supervised counselling and training sessions in energy conservation techniques by an occupational therapist. The telemedicine videoconferencing equipment was a computer containing a screen, a microphone, an on/off switch and a volume control. Thirty seven (74%) participants completed the programme, with improvements in health status assessed by the Clinical COPD Questionnaire and physical performance assessed by a sit-to-stand test and a timed-up-and-go test. There were no cases of patient fall or emergency contact with a general practitioner during the telemedicine training sessions. The study participants believed the telemedicine training and counselling was essential for getting started with being physically active in a secure manner. The business case showed that under the current financing system, the reimbursement to the hospital was slightly higher than the hospital expenditures. Thus, the business case for the hospital was positive. The organizational analysis indicated that the perceptions of the staff were that the telemedicine service had improved the continuity of the rehabilitation programme for the patients and enabled the patients’ everyday lives to be included in the treatment. This study showed that home-based supervised training and counselling via video conference is safe and feasible and that telemedicine can help to ensure more equitable access to supervised training in patients with severe COPD. Clinical Trials NCT02085187 (Date of registration 10.03.2014).

31 October 2022 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
IFIben Fasterholdt
Iben Fasterholdt
MNMohammad Naghavi-Behzad
Mohammad Naghavi-Behzad
BRBenjamin S.B. Rasmussen
Benjamin S.B. Rasmussen
TKTue Kjølhede
Tue Kjølhede
MSMette Maria Skjøth
Mette Maria Skjøth
KKKristian Kidholm
Kristian Kidholm
Background: Artificial intelligence (AI) is seen as one of the major disrupting forces in the future healthcare system. However, the assessment of the value of these new technologies is still unclear, and no agreed international health technology assessment-based guideline exists. This study provides an overview of the available literature in the value assessment of AI in the field of medical imaging.Methods: We performed a systematic scoping review of published studies between January 2016 and September 2020 using 10 databases (Medline, Scopus, ProQuest, Google Scholar, and six related databases of grey literature). Information about the context (country, clinical area, and type of study) and mentioned domains with specific outcomes and items were extracted. An existing domain classification, from a European assessment framework, was used as a point of departure, and extracted data were grouped into domains and content analysis of data was performed covering predetermined themes.Results: Seventy-nine studies were included out of 5890 identified articles. An additional seven studies were identified by searching reference lists, and the analysis was performed on 86 included studies. Eleven domains were identified: (1) health problem and current use of technology, (2) technology aspects, (3) safety assessment, (4) clinical effectiveness, (5) economics, (6) ethical analysis, (7) organisational aspects, (8) patients and social aspects, (9) legal aspects, (10) development of AI algorithm, performance metrics and validation, and (11) other aspects. The frequency of mentioning a domain varied from 20 to 78% within the included papers. Only 15/86 studies were actual assessments of AI technologies. The majority of data were statements from reviews or papers voicing future needs or challenges of AI research, i.e. not actual outcomes of evaluations.Conclusions: This review regarding value assessment of AI in medical imaging yielded 86 studies including 11 identified domains. The domain classification based on European assessment framework proved useful and current analysis added one new domain. Included studies had a broad range of essential domains about addressing AI technologies highlighting the importance of domains related to legal and ethical aspects.

3 October 2022 in International Journal of Technology Assessment in Health Care
Verified
Journal Article
Closed access
PDF file
IFIben Fasterholdt
Iben Fasterholdt
TKTue Kjølhede
Tue Kjølhede
MNMohammad Naghavi-Behzad
Mohammad Naghavi-Behzad
TSThomas Schmidt
Thomas Schmidt
QRQuinnie T.S. Rautalammi
Quinnie T.S. Rautalammi
BRBenjamin S.B. Rasmussen
Benjamin S.B. Rasmussen
Objectives: Artificial intelligence (AI) is seen as a major disrupting force in the future healthcare system. However, the assessment of the value of AI technologies is still unclear. Therefore, a multidisciplinary group of experts and patients developed a Model for ASsessing the value of AI (MAS-AI) in medical imaging. Medical imaging is chosen due to the maturity of AI in this area, ensuring a robust evidence-based model.Methods: MAS-AI was developed in three phases. First, a literature review of existing guides, evaluations, and assessments of the value of AI in the field of medical imaging. Next, we interviewed leading researchers in AI in Denmark. The third phase consisted of two workshops where decision makers, patient organizations, and researchers discussed crucial topics for evaluating AI. The multidisciplinary team revised the model between workshops according to comments.Results: The MAS-AI guideline consists of two steps covering nine domains and five process factors supporting the assessment. Step 1 contains a description of patients, how the AI model was developed, and initial ethical and legal considerations. In step 2, a multidisciplinary assessment of outcomes of the AI application is done for the five remaining domains: safety, clinical aspects, economics, organizational aspects, and patient aspects.Conclusions: We have developed an health technology assessment-based framework to support the introduction of AI technologies into healthcare in medical imaging. It is essential to ensure informed and valid decisions regarding the adoption of AI with a structured process and tool. MAS-AI can help support decision making and provide greater transparency for all parties.